Argan, Inc.
AGX
$579.87
+17.78%
Argan, Inc. is a U.S.-based construction firm providing engineering, procurement, construction, commissioning, and maintenance services primarily to the power generation market, including renewable energy, through its wholly-owned subsidiaries GPS, APC, TRC, and SMC. The company operates in three segments—Power Services, Industrial Services, and Teledata—with Power Services generating the majority of revenue, positioning it as a specialized contractor in the energy infrastructure space. The current investor narrative centers on Argan's explosive growth fueled by a massive, multi-year backlog from the AI data center build-out, which has driven the stock to nearly double year-to-date and attracted analyst upgrades. Recent news highlights surging natural gas demand from AI data centers and space exploration, further supporting Argan's role in the energy transition and data center infrastructure boom.…
AGX
Argan, Inc.
$579.87
Related headlines
Investment Opinion: Should I buy AGX Today?
Rating: Buy. Argan is a high-growth infrastructure play benefiting from the AI data center build-out, with strong financials and a massive backlog. The consensus analyst rating leans bullish (2 Buy, 2 Hold, 1 Overweight) with an average target of $679.80, implying 19.5% upside.
Supporting Evidence: Revenue grew 50.2% YoY to $290.95M, with net margin expanding to 15.8% from 11.6%. The PEG ratio of 0.60 suggests undervaluation relative to growth, and the company has zero debt with TTM free cash flow of $486.89M. The trailing P/E of 34.7x is above the industry average of 22x, but the growth premium is justified by the accelerating revenue trajectory and expanding margins. Analyst estimates project FY2027 EPS of $14.24, implying a forward P/E of 35.0x, which is reasonable for a company growing at 50%.
Risks & Conditions: The biggest risks are growth deceleration and valuation compression. If revenue growth falls below 20%, the stock could re-rate to a P/E of 25x, implying a target of ~$355 (37% downside). Conversely, if growth accelerates or margins expand further, the stock could reach the high target of $860. This Buy rating would be downgraded to Hold if the stock approaches $800 without a commensurate increase in earnings estimates, or if the backlog shows signs of slowing. Overall, Argan appears fairly valued to slightly undervalued given its growth rate, but investors should monitor quarterly results for signs of deceleration.
Sign up to view all
AGX 12-Month Price Forecast
Argan's growth story is compelling, with a massive backlog and strong execution driving 50%+ revenue growth. The stock has pulled back from its highs, offering a potential entry point, but valuation is elevated relative to peers. The base case of 30-40% growth and a target of $600-$750 is most likely, supported by analyst consensus. However, the wide target spread and recent negative momentum warrant caution. The stance is bullish with medium confidence, as the risk/reward is favorable if growth sustains, but a deceleration could lead to significant downside. Upgrades to high confidence would require evidence of accelerating backlog or margin expansion; downgrades would follow a sustained drop in revenue growth below 20%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Argan, Inc.'s 12-month outlook, with a consensus price target around $679.80 and implied upside of +17.2% versus the current price.
Average Target
$679.80
0 analysts
Implied Upside
+17.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$500 - $860
Analyst target range
Argan is covered by 5 analysts, with a consensus recommendation leaning bullish. The average target price is $679.80, implying approximately 19.5% upside from the current price of $568.92. The distribution shows 2 Buy ratings (Goldman Sachs, GLJ Research), 2 Hold ratings (Lake Street, JP Morgan previously Neutral but recently upgraded to Overweight), and 1 Overweight (JP Morgan). The consensus is not purely bullish but leans positive, with no Sell ratings. The target price range spans from a low of $500.00 to a high of $860.00, indicating a wide spread of 72% from low to high, reflecting high uncertainty about the company's future. The high target of $860.00 assumes continued acceleration in AI data center demand and margin expansion, while the low target of $500.00 prices in potential competitive pressures or a slowdown in project awards. Recent rating actions show upgrades: JP Morgan moved from Neutral to Overweight in March 2026, and GLJ Research upgraded from Hold to Buy in November 2025. Lake Street downgraded from Buy to Hold in December 2025 but has maintained Hold since. The wide target spread and mixed ratings suggest that while the growth story is compelling, there is significant debate about the sustainability of the backlog and valuation.
Bulls vs Bears: AGX Investment Factors
Argan presents a compelling growth story with 50.2% revenue growth, expanding margins, and a debt-free balance sheet, supported by a massive backlog from AI data center infrastructure. The stock has pulled back 22% from its highs, offering a potential entry point, but trades at a 58% premium to industry P/E. The bull case hinges on sustained AI-driven demand and margin expansion, while the bear case centers on valuation risk and potential growth deceleration. The single most important tension is whether the current growth rate is sustainable; if revenue growth remains above 30%, the stock likely has further upside, but a slowdown below 20% could trigger a significant de-rating. Overall, the bull case currently has stronger evidence given the backlog and analyst upgrades, but the recent price action warrants caution.
Bullish
- Explosive Revenue Growth: Revenue surged 50.2% YoY to $290.95M in Q1 FY2027, driven by AI data center demand. This acceleration from prior quarters (e.g., $193.66M a year ago) demonstrates strong execution and a multi-year backlog.
- Expanding Profit Margins: Gross margin improved to 21.0% from 19.0% YoY, and net margin rose to 15.8% from 11.6%. Operating leverage is evident as operating margin expanded to 15.6% from 12.6%, reflecting scale benefits.
- Pristine Balance Sheet: Debt-to-equity is just 0.014, with a current ratio of 1.60. Free cash flow of $110.95M in Q1 (up from $34.90M) and TTM FCF of $486.89M provide ample liquidity for growth and shareholder returns.
- Attractive PEG Ratio: With a PEG ratio of 0.60, the stock appears undervalued relative to its growth rate. The trailing P/E of 34.7x is justified by 50%+ revenue growth, compared to the industry average P/E of ~22x.
Bearish
- Sharp Recent Price Decline: The stock has fallen 22.3% in the past month and 12.9% in three months, underperforming the S&P 500 by 23.1% and 16.4% respectively. This negative momentum could signal a deeper correction or mean reversion.
- Premium Valuation vs. Peers: Trailing P/E of 34.7x is a 58% premium to the industry average of ~22x. While growth justifies some premium, any slowdown could lead to multiple compression and significant downside.
- Wide Analyst Target Spread: Analyst targets range from $500 to $860, a 72% spread, indicating high uncertainty. The low target implies 12% downside from current levels, reflecting risks of competitive pressures or project delays.
- Concentration Risk in Power Services: Power Services generated $226.67M of $290.95M in Q1 revenue (78% of total). Over-reliance on the AI data center build-out makes the company vulnerable to shifts in tech capex or energy policy.
AGX Technical Analysis
Argan is in a powerful long-term uptrend, with the stock up 153.6% over the past year, dramatically outperforming the S&P 500's 16.5% gain. The current price of $568.92 sits at 70.6% of its 52-week range ($197.00 to $805.75), indicating the stock is still in the upper half of its range but has pulled back from the highs. This positioning suggests the uptrend remains intact but has cooled from peak momentum, offering a potential entry point for trend-followers if support holds. Short-term momentum has turned sharply negative, with the stock down 22.3% over the past month and 12.9% over the past three months, diverging from the strong one-year trend. This divergence could signal a temporary pullback or mean reversion within a larger uptrend, especially given the stock's beta of 0.564, which indicates lower volatility than the market. The relative strength index (not provided) would likely show oversold conditions after such a sharp decline, suggesting a potential bounce. Key support lies at the 52-week low of $197.00, though the more immediate support is around the recent low of $547.51 from July 16. Resistance is at the 52-week high of $805.75. A breakout above $805.75 would signal a resumption of the uptrend, while a breakdown below $547.51 could lead to further downside. With a beta of 0.564, Argan is less volatile than the market, meaning its pullbacks may be shallower and recoveries slower than high-beta names.
Beta
0.56
0.56x market volatility
Max Drawdown
-38.3%
Largest decline past year
52-Week Range
$197-$806
Price range past year
Annual Return
+141.1%
Cumulative gain past year
| Period | AGX Return | S&P 500 |
|---|---|---|
| 1m | -27.4% | -0.7% |
| 3m | -17.4% | +2.9% |
| 6m | +67.1% | +7.2% |
| 1y | +141.1% | +16.9% |
| ytd | +77.9% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AGX Fundamental Analysis
Argan's revenue trajectory is strongly accelerating, with the most recent quarter (Q1 FY2027, ended April 30, 2026) reporting revenue of $290.95 million, a 50.2% year-over-year increase. This marks a significant acceleration from the prior four quarters' revenue of $262.05M, $251.15M, $237.74M, and $193.66M, respectively. The Power Services segment drove the bulk of revenue at $226.67 million, while Industrial Fabrication contributed $58.30 million, indicating the AI data center build-out is a key catalyst. The company is highly profitable, with net income of $46.06 million in the most recent quarter, up from $22.55 million a year ago. Gross margin improved to 21.0% from 19.0% in the year-ago quarter, while operating margin expanded to 15.6% from 12.6%, reflecting operating leverage. Net margin rose to 15.8% from 11.6%, demonstrating strong profitability improvement. Argan's balance sheet is pristine, with virtually no debt (debt-to-equity ratio of 0.014) and a current ratio of 1.60, indicating ample liquidity. Free cash flow was $110.95 million in Q1, up from $34.90 million a year ago, and trailing twelve-month free cash flow reached $486.89 million. ROE is a robust 29.8%, and the company generated $113.38 million in operating cash flow in Q1, more than covering its minimal capex of $2.43 million. This financial strength allows Argan to fund growth internally and return capital to shareholders via dividends and buybacks.
Quarterly Revenue
$290954000.0B
2026-04
Revenue YoY Growth
+50.2%
YoY Comparison
Gross Margin
21.0%
Latest Quarter
Free Cash Flow
$486894000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AGX Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 34.7x, while the forward P/E is 35.0x, implying the market expects earnings to remain stable or grow modestly. The slight premium in the forward multiple suggests analysts anticipate continued earnings growth, consistent with the company's strong revenue trajectory. Compared to the Engineering & Construction industry, Argan trades at a significant premium. The industry average P/E is approximately 22x (based on typical sector multiples), making Argan's trailing P/E of 34.7x a 58% premium. This premium is justified by Argan's superior growth (50%+ revenue growth vs. industry average of ~10%), expanding margins, and strong balance sheet. Historically, Argan's P/E has ranged from a low of 9.7x (in Q4 FY2023) to a high of 63.5x (in Q1 FY2024). The current trailing P/E of 34.7x is near the middle of this range, suggesting the stock is not excessively overvalued relative to its own history. However, the P/E has compressed from 50.8x in Q1 FY2027, indicating that earnings growth has caught up with the stock price. The PEG ratio of 0.60 suggests the stock is undervalued relative to its growth rate, as a PEG below 1.0 typically indicates undervaluation.
PE
34.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
27.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Argan's financials are strong, but the company faces operational risks from its concentrated revenue base. Power Services accounts for 78% of Q1 revenue, making it highly dependent on the AI data center build-out. While the backlog is multi-year, any delays in project awards or cancellations could impact revenue visibility. The company has virtually no debt (D/E 0.014), so financial leverage is not a concern, but the high growth rate (50.2% YoY) may be difficult to sustain, and a deceleration could pressure margins. Free cash flow is robust at $486.89M TTM, but the payout ratio of 17.6% and dividend yield of 0.5% are modest, limiting income appeal.
Market & Competitive Risks: Argan trades at a significant premium to its industry (P/E 34.7x vs. 22x), making it vulnerable to valuation compression if growth slows. The stock's beta of 0.564 suggests lower volatility than the market, but the recent 22.3% monthly decline shows it can still experience sharp drawdowns. Competitive risks include larger E&C firms entering the AI data center space, which could pressure margins. Regulatory risks are moderate, but changes in energy policy or tax incentives for renewable energy could impact project economics. Recent news highlights surging natural gas demand from AI data centers, which supports Argan's thesis, but any shift toward alternative energy sources could reduce demand for gas-fired power plants.
Worst-Case Scenario: In a severe downturn, a combination of slowing AI capex, project cancellations, and margin compression could drive the stock to its 52-week low of $197.00, representing a 65.4% decline from the current price of $568.92. This scenario would likely require a recession or a sharp pullback in technology spending. The analyst low target of $500.00 implies a more moderate 12.1% downside, but the worst case could be more severe if the growth story unravels. Historical max drawdown of -31.44% suggests the stock has experienced significant corrections before, and a repeat could bring the price to around $390.
FAQ
The primary risk is growth deceleration: if revenue growth falls below 20%, the stock could de-rate significantly, as the current P/E of 34.7x relies on high growth expectations. Second, concentration risk is high, with Power Services accounting for 78% of revenue, making AGX vulnerable to shifts in AI data center spending. Third, competitive risk from larger E&C firms could pressure margins. Finally, macro risks include a recession or higher interest rates that could delay project financing. The most severe risk is a 65% decline to the 52-week low of $197 if the growth story unravels. Investors should monitor quarterly earnings and backlog trends closely.
Analysts forecast a 12-month target range of $500 to $860, with an average of $679.80, implying 19.5% upside from the current price of $568.92. The base case (45% probability) expects revenue growth of 30-40% and a target of $600-$750. The bull case (30% probability) sees growth above 60% and a target of $750-$860, while the bear case (25% probability) assumes growth below 20% and a target of $400-$500. The most likely scenario is the base case, driven by sustained AI data center demand. However, the wide spread reflects high uncertainty, and actual results could vary significantly.
AGX's trailing P/E of 34.7x is a 58% premium to the Engineering & Construction industry average of ~22x, suggesting it is overvalued relative to peers. However, the PEG ratio of 0.60 indicates it is undervalued relative to its growth rate, as a PEG below 1.0 typically signals undervaluation. Historically, AGX's P/E has ranged from 9.7x to 63.5x, and the current 34.7x is near the middle, implying it is fairly valued relative to its own history. The market is pricing in continued strong growth, and if revenue growth sustains above 30%, the valuation is justified. Overall, AGX is fairly valued to slightly undervalued given its growth trajectory, but it is not a bargain on a pure P/E basis.
AGX presents a compelling risk/reward for growth investors, with 19.5% upside to the average analyst target of $679.80 and a PEG ratio of 0.60 suggesting undervaluation relative to its 50%+ growth rate. However, the stock has pulled back 22% in the past month and trades at a 58% premium to the industry P/E, so timing is important. The biggest downside risk is a growth deceleration, which could lead to multiple compression and a drop to the low target of $500 (12% downside). For investors with a high risk tolerance and a long-term horizon (3-5 years), AGX is a good buy at current levels, but conservative investors may want to wait for a better entry or confirmation of sustained growth.
AGX is better suited for long-term investment (3-5 years) given its high growth and multi-year backlog, which provides visibility into future revenue. The stock's beta of 0.564 indicates lower volatility than the market, but it has experienced sharp pullbacks (22% in the past month), making it risky for short-term trading. The dividend yield is only 0.5%, so income is not a factor. For long-term investors, the compounding effect of 30-50% growth could generate substantial returns, but short-term traders should be cautious of momentum reversals. A minimum holding period of 3 years is recommended to ride out volatility and allow the backlog to convert into earnings.